Department of Pathology, The Jake Gittlen Laboratories for Cancer Research, Hershey, PA 17033, USA.
Int J Mol Sci. 2018 Oct 20;19(10):3255. doi: 10.3390/ijms19103255.
Incomplete and low-fidelity genome duplication contribute to genomic instability and cancer development. Difficult-to-Replicate Sequences, or DiToRS, are natural impediments in the genome that require specialized DNA polymerases and repair pathways to complete and maintain faithful DNA synthesis. DiToRS include non B-DNA secondary structures formed by repetitive sequences, for example within chromosomal fragile sites and telomeres, which inhibit DNA replication under endogenous stress conditions. Oncogene activation alters DNA replication dynamics and creates oncogenic replication stress, resulting in persistent activation of the DNA damage and replication stress responses, cell cycle arrest, and cell death. The response to oncogenic replication stress is highly complex and must be tightly regulated to prevent mutations and tumorigenesis. In this review, we summarize types of known DiToRS and the experimental evidence supporting replication inhibition, with a focus on the specialized DNA polymerases utilized to cope with these obstacles. In addition, we discuss different causes of oncogenic replication stress and its impact on DiToRS stability. We highlight recent findings regarding the regulation of DNA polymerases during oncogenic replication stress and the implications for cancer development.
不完全和低保真度的基因组复制会导致基因组不稳定和癌症的发生。难以复制的序列(Difficult-to-Replicate Sequences,DiToRS)是基因组中的天然障碍,需要专门的 DNA 聚合酶和修复途径来完成并维持忠实的 DNA 合成。DiToRS 包括由重复序列形成的非 B-DNA 二级结构,例如在染色体脆性位点和端粒内,这些结构会在体内应激条件下抑制 DNA 复制。癌基因的激活改变了 DNA 复制动力学,并产生致癌性的复制应激,导致持续激活 DNA 损伤和复制应激反应、细胞周期停滞和细胞死亡。对致癌性复制应激的反应非常复杂,必须进行严格的调控,以防止突变和肿瘤发生。在这篇综述中,我们总结了已知的 DiToRS 类型和支持复制抑制的实验证据,重点介绍了用于应对这些障碍的专门 DNA 聚合酶。此外,我们还讨论了致癌性复制应激的不同原因及其对 DiToRS 稳定性的影响。我们强调了关于癌基因复制应激期间 DNA 聚合酶调控的最新发现及其对癌症发展的影响。